bpc-157 safety risks side effects Effects: What Research Shows The Hidden Risks of BPC‑157:

In such a protocol, it's common to administer the BPC-157 locally to the ankle and the TB-500 systemically in the abdomen, leveraging the theoretical strengths of each compound's primary mechanism of action

The location and intensity depend on which bursa is affected

All products are for laboratory research purposes only

When to Discard BPC-157 Discard BPC-157 if the solution becomes cloudy, changes color, develops visible particles, leaks, has a damaged stopper, or has an unknown reconstitution date

Extended 12-Week Protocol (Optional) Note: The 12-week extension reaches higher daily doses (10001300 mcg) explored in performance and metabolic research